Compare Sanofi India with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs TTK HEALTHCARE - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA TTK HEALTHCARE SANOFI INDIA/
TTK HEALTHCARE
 
P/E (TTM) x 40.9 10.6 384.4% View Chart
P/BV x 8.3 1.5 539.0% View Chart
Dividend Yield % 1.0 1.0 104.7%  

Financials

 SANOFI INDIA   TTK HEALTHCARE
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
TTK HEALTHCARE
Mar-19
SANOFI INDIA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs6,8401,215 563.0%   
Low Rs4,630610 758.9%   
Sales per share (Unadj.) Rs1,203.1444.4 270.8%  
Earnings per share (Unadj.) Rs165.317.2 958.2%  
Cash flow per share (Unadj.) Rs209.927.6 759.5%  
Dividends per share (Unadj.) Rs84.005.00 1,680.0%  
Dividend yield (eoy) %1.50.5 267.3%  
Book value per share (Unadj.) Rs963.6177.9 541.5%  
Shares outstanding (eoy) m23.0314.13 163.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.82.1 232.1%   
Avg P/E ratio x34.752.9 65.6%  
P/CF ratio (eoy) x27.333.0 82.7%  
Price / Book Value ratio x6.05.1 116.1%  
Dividend payout %50.829.0 175.3%   
Avg Mkt Cap Rs m132,07812,894 1,024.3%   
No. of employees `0003.32.3 142.8%   
Total wages/salary Rs m4,0681,307 311.2%   
Avg. sales/employee Rs Th8,393.82,715.7 309.1%   
Avg. wages/employee Rs Th1,232.4565.3 218.0%   
Avg. net profit/employee Rs Th1,153.0105.4 1,093.8%   
INCOME DATA
Net Sales Rs m27,7086,279 441.3%  
Other income Rs m89778 1,157.4%   
Total revenues Rs m28,6056,356 450.0%   
Gross profit Rs m6,235496 1,258.1%  
Depreciation Rs m1,027147 700.1%   
Interest Rs m734 20.7%   
Profit before tax Rs m6,098393 1,553.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292149 1,539.3%   
Profit after tax Rs m3,806244 1,561.8%  
Gross profit margin %22.57.9 285.1%  
Effective tax rate %37.637.9 99.1%   
Net profit margin %13.73.9 353.9%  
BALANCE SHEET DATA
Current assets Rs m15,9222,717 586.0%   
Current liabilities Rs m6,2351,571 396.9%   
Net working cap to sales %35.018.3 191.5%  
Current ratio x2.61.7 147.6%  
Inventory Days Days6432 197.9%  
Debtors Days Days2147 44.7%  
Net fixed assets Rs m7,539991 760.7%   
Share capital Rs m230141 162.8%   
"Free" reserves Rs m21,9622,373 925.5%   
Net worth Rs m22,1922,514 882.6%   
Long term debt Rs m03 0.0%   
Total assets Rs m29,8394,158 717.6%  
Interest coverage x872.112.6 6,913.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.91.5 61.5%   
Return on assets %12.86.7 191.5%  
Return on equity %17.29.7 176.9%  
Return on capital %27.516.9 162.4%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m7,587225 3,369.0%   
Fx outflow Rs m7,14571 10,047.8%   
Net fx Rs m442154 286.8%   
CASH FLOW
From Operations Rs m3,739173 2,160.0%  
From Investments Rs m-73197 -757.5%  
From Financial Activity Rs m-1,972-307 641.7%  
Net Cashflow Rs m1,036-38 -2,748.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 3.7 389.2%  
FIIs % 14.6 5.2 280.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 25.8 40.7%  
Shareholders   15,184 12,723 119.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   CIPLA  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  PIRAMAL ENTERPRISES  

Compare SANOFI INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Recover From Day's Low to End Strong; TCS & Wipro Rally Over 3.5%(Closing)

Indian share markets recouped early losses during closing hours and ended today's volatile session higher, helped by gains in metals and banking stocks.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday(Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Apr 15, 2021 03:37 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS